W.R. Berkley Corp’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
LA
KC
MF
AA
WAM
MC
HCM
LP
TCM
AIMCA
W.R. Berkley Corp's TDAC Position: Q2 2026 in Review
W.R. Berkley Corp increased its Translational Development Acquisition Corp (TDAC) stake by 18% in Q2 2026, buying an estimated $531K and bringing the position to 322,658 shares worth $3.45M. The position accounts for 0.16% of the portfolio, ranked #121.
W.R. Berkley Corp first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.
- W.R. Berkley Corp held 322,658 shares of Translational Development Acquisition Corp worth $3.45M as of Q2 2026.
- W.R. Berkley Corp bought 49,708 Translational Development Acquisition Corp shares in Q2 2026, an estimated $531K.
- Translational Development Acquisition Corp made up 0.16% of W.R. Berkley Corp's portfolio in Q2 2026, its #121 holding.
- W.R. Berkley Corp first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
- 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.
Based on W.R. Berkley Corp's 13F filing for Q2 2026, filed 14 Aug 2026.